Characterizing and assessing antiemetic underuse in patients initiating highly emetogenic chemotherapy

被引：0
|
作者：
Nirosha Mahendraratnam
Joel F. Farley
Ethan Basch
Amber Proctor
Stephanie B. Wheeler
Stacie B. Dusetzina
机构：
[1] University of North Carolina at Chapel Hill,UNC Eshelman School of Pharmacy
[2] UNC Eshelman School of Pharmacy,Division of Pharmaceutical Outcomes and Policy
[3] University of Minnesota College of Pharmacy,Gillings School of Global Public Health
[4] University of North Carolina at Chapel Hill,Lineberger Comprehensive Cancer Center
[5] University of North Carolina at Chapel Hill,undefined
[6] Vanderbilt-Ingram Cancer Center,undefined
[7] Vanderbilt University School of Medicine,undefined
来源：
Supportive Care in Cancer | 2019年 / 27卷
关键词：
Antiemetics; Clinical guidelines; Value-based care; Claims data; Chemotherapy-induced nausea and vomiting;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4525 / 4534
页数：9
相关论文
共 50 条
  • [1] Characterizing and assessing antiemetic underuse in patients initiating highly emetogenic chemotherapy
    Mahendraratnam, Nirosha
    Farley, Joel F.
    Basch, Ethan
    Proctor, Amber
    Wheeler, Stephanie B.
    Dusetzina, Stacie B.
    SUPPORTIVE CARE IN CANCER, 2019, 27 (12) : 4525 - 4534
  • [2] Antiemetic Regimen with Olanzapine in Pediatric Patients Receiving Highly Emetogenic Chemotherapy
    Rasheed, Azgar A.
    Bakhshi, Sameer
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (04) : 366 - 369
  • [3] ASSOCIATION OF ABC POLYMORPHISM WITH ANTIEMETIC EFFICACY IN CANCER PATIENTS TREATED WITH HIGHLY EMETOGENIC CHEMOTHERAPY
    Tsuji, Daiki
    Kim, Yong-Il
    Daimon, Takashi
    Makuta, Ryo
    Homma, Chiho
    Nakamichi, Hidenori
    Yamamoto, Keisuke
    Hayashi, Hideki
    Inoue, Kazuyuki
    Itoh, Kunihiko
    ANNALS OF ONCOLOGY, 2014, 25
  • [4] Adherence to antiemetic guidelines in solid cancer patients receiving highly emetogenic chemotherapy in Korea
    Ryugyoung Lee
    Minhee Ku
    Nam Kyung Je
    Supportive Care in Cancer, 2024, 32
  • [5] Adherence to antiemetic guidelines in solid cancer patients receiving highly emetogenic chemotherapy in Korea
    Lee, Ryugyoung
    Ku, Minhee
    Je, Nam Kyung
    SUPPORTIVE CARE IN CANCER, 2024, 32 (03)
  • [6] Ten-Year Trends in Antiemetic Prescribing in Patients Receiving Highly Emetogenic Chemotherapy
    O'Sullivan, Ciara C.
    Van Houten, Holly K.
    Sangaralingham, Lindsey R.
    Leal, Alexis D.
    Shinde, Shivani
    Liu, Hongfang
    Ettinger, David
    Loprinzi, Charles L.
    Ruddy, Kathryn J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (03): : 294 - 299
  • [7] CHANGES IN ANTIEMETIC PRESCRIBING PRACTICES FOR CHILDREN RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY
    Davis, Matthew
    Rosenman, Marc
    Bendelow, Anne
    Goldman, Stewart
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [8] Ten year trends in antiemetic prescribing in cancer patients receiving highly emetogenic chemotherapy (HEC)
    O'Sullivan, Ciara C.
    Van Houten, Holly K.
    Sangaralingham, Lindsey
    Leal, Alexis D.
    Shinde, Shivani
    Liu, Hongfang
    Ettinger, David
    Loprinzi, Charles L.
    Ruddy, Kathryn J.
    CANCER RESEARCH, 2018, 78 (04)
  • [9] Efficacy of Olanzapine Combined Therapy for Patients Receiving Highly Emetogenic Chemotherapy Resistant to Standard Antiemetic Therapy
    Abe, Masakazu
    Kasamatsu, Yuka
    Kado, Nobuhiro
    Kuji, Shiho
    Tanaka, Aki
    Takahashi, Nobutaka
    Takekuma, Munetaka
    Hirashima, Yasuyuki
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [10] Antiemetic Efficacy of a Palonosetron-Dexamethasone Schedule in Pediatric Patients Treated with Moderately or Highly Emetogenic Chemotherapy
    Varrasso, G.
    De Grazia, A.
    Ferrara, E.
    Paiano, M.
    Mattiucci, C.
    Pedetti, V.
    Schiavetti, A.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S550 - S550
12345